Bulk Manufacturer of Controlled Substances Application: Noramco Inc.
| Published date | 22 October 2020 |
| Citation | 85 FR 67374 |
| Record Number | 2020-23396 |
| Section | Notices |
| Court | Drug Enforcement Administration,Justice Department |
Federal Register, Volume 85 Issue 205 (Thursday, October 22, 2020)
[Federal Register Volume 85, Number 205 (Thursday, October 22, 2020)]
[Notices]
[Pages 67374-67375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23396]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-734]
Bulk Manufacturer of Controlled Substances Application: Noramco
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Noramco Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 21,
2020. Such persons may also file a written request
[[Page 67375]]
for a hearing on the application on or before December 21, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on October 6, 2020, Noramco Inc. 500 Swedes Landing
Road, Wilmington, Delaware 19801-4417, applied to be registered as an
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Codeine-N-oxide.................... 9053 I
Dihydromorphine.................... 9145 I
Hydromorphinol..................... 9301 I
Morphine-N-oxide................... 9307 I
Amphetamine........................ 1100 II
Lisdexamfetamine................... 1205 II
Methylphenidate.................... 1724 II
Nabilone........................... 7379 II
Phenylacetone...................... 8501 II
Codeine............................ 9050 II
Dihydrocodeine..................... 9120 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Hydrocodone........................ 9193 II
Morphine........................... 9300 II
Oripavine.......................... 9330 II
Thebaine........................... 9333 II
Opium extracts..................... 9610 II
Opium fluid extract................ 9620 II
Opium tincture..................... 9630 II
Opium, powdered.................... 9639 II
Opium, granulated.................. 9640 II
Oxymorphone........................ 9652 II
Noroxymorphone..................... 9668 II
Tapentadol......................... 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as an Active Pharmaceutical Ingredient (API) for supply to its
customers. In reference to drug codes 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-23396 Filed 10-21-20; 8:45 am]
BILLING CODE P
